NCT03390114
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
- Locations
-
- Infectious Diseases Research Center Indianapolis, Indiana, United States
Clinical trial condition
Immunologic Deficiency Syndromes
Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.
6,132 public trials
395 recruiting studies
Immunologic Deficiency Syndromes trial results
NCT02693145
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Connecticut Department of Public Health Hartford, Connecticut, United States
- Massachusetts Department of Public Health Boston, Massachusetts, United States
- Philadelphia Department of Health Philadelphia, Pennsylvania, United States
Completed
Simplified Monitoring Myanmar SM2 Study
NCT04113629
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
- Locations
-
- The Kirby Institute, University of New South Wales Australia Sydney, New South Wales, Australia
NCT03308097
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- University of Mississippi Medical Center Jackson, Mississippi, United States
Completed
Glutathione and Function in HIV Patients
NCT02348775
- Conditions
- Blood-Borne Infections, Communicable Diseases, Erythrocyte Glutathione Deficiency, +13 more
- Locations
-
- Baylor Metabolic Research Unit (MRU) Houston, Texas, United States
NCT01229579
- Conditions
- Blood-Borne Infections, Central Nervous System Diseases, Central Nervous System Infections, +26 more
- Locations
-
- Project Office, Aga Khan University, Matiari Matiari, Sindh, Pakistan
NCT02953080
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Infectious Diseases Institute,Makerere University College of Health Sciences Kampala, Uganda
NCT03784079
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- GSK Investigational Site Bakersfield, California, United States
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Marseille, France
- GSK Investigational Site Paris, France
Completed
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
NCT01581593
- Conditions
- Agammaglobulinemia, Antibody Deficiency, Blood Protein Disorders, +11 more
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
- Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
- Rush University Chicago, Illinois, United States
NCT03576469
- Conditions
- Angioedema, Angioedemas, Hereditary, CVI - Common Variable Immunodeficiency, +17 more
- Locations
-
- IMMUNOe Research Centers Centennial, Colorado, United States